Positive newborn screen in a normal infant of a mother with asymptomatic very long-chain Acyl-CoA dehydrogenase deficiency

J Pediatr. 2011 Jun;158(6):1031-2. doi: 10.1016/j.jpeds.2011.01.063. Epub 2011 Mar 22.

Abstract

A neonate with elevated tetradecenoylcarnitine (C14:1) on the newborn screen was evaluated for possible very long-chain acyl-CoA dehydrogenase deficiency (VLCADD) and found to be a carrier. However, his symptom-free mother was subsequently diagnosed with VLCADD. This documents maternal VLCADD causing a positive newborn screening result in an offspring.

Publication types

  • Case Reports

MeSH terms

  • Acyl-CoA Dehydrogenase, Long-Chain / blood
  • Acyl-CoA Dehydrogenase, Long-Chain / deficiency
  • Carnitine / analogs & derivatives
  • Carnitine / blood
  • Congenital Bone Marrow Failure Syndromes
  • Female
  • Genotype
  • Humans
  • Infant, Newborn
  • Lipid Metabolism, Inborn Errors
  • Male
  • Metabolism, Inborn Errors / blood
  • Metabolism, Inborn Errors / diagnosis
  • Mitochondrial Diseases / blood
  • Mitochondrial Diseases / diagnosis
  • Mothers
  • Muscular Diseases / blood
  • Muscular Diseases / diagnosis
  • Neonatal Screening / methods*
  • Phenotype

Substances

  • acylcarnitine
  • Acyl-CoA Dehydrogenase, Long-Chain
  • Carnitine

Supplementary concepts

  • VLCAD deficiency